ID   HAP1 GALK2 (-) NAGK (-)
AC   CVCL_DX36
SY   HZGHC007492c010; Double knockout cell line GALK2 1bp insertion in exon 8 and NAGK 29bp deletion in exon 3
DR   Horizon_Discovery; HZGHC007492c010
DR   Wikidata; Q127381049
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4119; GALK2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17174; NAGK.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DX01 ! HAP1 GALK2 (-) 1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//